Benefits of nanotechnology in treating cancer

dc.contributor.authorTuominen, Eveliina
dc.contributor.departmentfi=Lääketieteellisen tiedekunnan yhteiset|en=Common / Faculty of Medicine|
dc.contributor.facultyfi=Lääketieteellinen tiedekunta|en=Faculty of Medicine|
dc.contributor.studysubjectfi=LL-tutkinto, syventävät opinnot|en=Advanced Studies in Medicine|
dc.date.accessioned2024-03-14T22:03:38Z
dc.date.available2024-03-14T22:03:38Z
dc.date.issued2024-03-08
dc.description.abstractThis literature review addresses the benefits of nanotechnology in treating cancer. The nanotechnology field has aroused enormous interest among researchers due to its possibilities. The purpose of nanotechnology is to improve existing processes and its use extends to various fields, including medicine and the food industry. Nanotechnology utilizes 1-100 nm size particles, and nanoscale principles and methods. In nanomedicine, nanoparticles are used to transport cargo within the human body. Nanomedicine has acted as a promising technology for cancer treatment. To synthesize effective and functional nanoparticles, a comprehensive understanding of cancer characteristics is crucial. Several physicochemical modifications can be made to the nanoparticles to optimize their performance. These modifications include changes in the size, charge, shape, as well as the optical and magnetic properties of nanoparticles, along with the addition of various surface agents. Modifying these properties presents an opportunity to overcome the limitations of traditional chemotherapy, including rapid clearance, side effects and toxicity. Nanomedicine provides solutions to reduce drug resistance in cancer cells. Furthermore, it enables the combination of various treatment strategies, targeted drug delivery, controlled release, and real-time monitoring of the treatment process. These approaches, coupled with the opportunities offered by nanoparticles, nanotechnology emerge as a promising avenue for enhancing cancer treatment while minimizing side effects.
dc.format.extent42
dc.identifier.olddbid193559
dc.identifier.oldhandle10024/176616
dc.identifier.urihttps://www.utupub.fi/handle/11111/18649
dc.identifier.urnURN:NBN:fi-fe2024031411311
dc.language.isoeng
dc.rightsfi=Julkaisu on tekijänoikeussäännösten alainen. Teosta voi lukea ja tulostaa henkilökohtaista käyttöä varten. Käyttö kaupallisiin tarkoituksiin on kielletty.|en=This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.|
dc.rights.accessrightsavoin
dc.source.identifierhttps://www.utupub.fi/handle/10024/176616
dc.subjectnanotechnology, nanoparticles, cancer, targeted delivery, controlled release, combined therapy
dc.titleBenefits of nanotechnology in treating cancer
dc.type.ontasotfi=Syventävien opintojen kirjallinen työ|en=Second Cycle degree thesis|

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
Tuominen_Eveliina_opinnayte.pdf
Size:
1.08 MB
Format:
Adobe Portable Document Format